טוען...
A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy
BACKGROUND: Nucleos(t)ide analogues reduce the incidence of hepatitis B virus (HBV) reactivation in cancer patients undergoing systemic cytotoxic chemotherapy but the experience of solid tumors remains limited. Aims. The aim of this study was to compare the efficacy of entecavir and lamivudine in th...
שמור ב:
הוצא לאור ב: | PLoS One |
---|---|
Main Authors: | , , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Public Library of Science
2015
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4488285/ https://ncbi.nlm.nih.gov/pubmed/26121480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0131545 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|